Deborah Pietrobono

Deborah Pietrobono

Auto-generated profile, based on publicly available information

Deborah Pietrobono

Department of Pharmacy, University of Pisa, 56126 Pisa, Italy

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Simona SestitoSimona Sestito
Simona Sestito
SDSimona Daniele
Simona Daniele
DPDeborah Pietrobono
Deborah Pietrobono
VCValentina Citi
Valentina Citi
LBLorenza Bellusci
Lorenza Bellusci
Simona RapposelliSimona Rapposelli
Simona Rapposelli
Hydrogen sulphide has recently drawn much attention due to its potent anti-inflammatory and neuroprotective roles in brain functions. The purpose of the current study was to exploit these beneficial properties of H2S to design a new agent for the treatment of Alzheimer’s disease (AD). To pursue our aims, we replaced the free amine group of memantine with an isothiocyanate functionality as a putative H2S-donor moiety. The new chemical entity, named memit, was then tested in vitro to determine whether it retains the pharmacological profile of the “native drug”, while also providing a source of H2S in the CNS. Indeed, Memit showed the ability to release H2S through a cysteine-mediated mechanism, thus generating memantine. Moreover, the new hybrid molecule exerts protective effects against neuronal inflammation and induces a drastic fall in ROS production. In addition, memit was also able to reduce the Aβ(1-42) self-induced aggregation and exerted cytoprotective effect against Aβ oligomers-induced damage in both human neurons and rat microglia cells. Finally, similarly to memantine, the new compound promotes autophagy, a complex process required for cellular homeostasis in cell survival that results to be altered in neurodegenerative diseases. In conclusion, our study revealed that memit is a prodrug of memantine. Further in vivo studies will be necessary to fully investigate the synergic or cumulative effects due to the H2S-releasing moiety and the native drug.

22 February 2018 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
PDF file
SIMONA DANIELESIMONA DANIELE
SIMONA DANIELE
DFDaniela Frosini
Daniela Frosini
DPDeborah Pietrobono
Deborah Pietrobono
LPLucia Petrozzi
Lucia Petrozzi
AGAnnalisa Lo Gerfo
Annalisa Lo Gerfo
UBUbaldo Bonuccelli
Ubaldo Bonuccelli
Neurodegenerative disorders (NDs) are characterized by abnormal accumulation/misfolding of specific proteins, primarily α-synuclein (α-syn), β-amyloid1–42 (Aβ1–42) and tau, in both brain and peripheral tissues. In addition to oligomers, the role of the interactions of α-syn with Aβ or tau has gradually emerged. Nevertheless, despite intensive research, NDs have no accepted peripheral markers for biochemical diagnosis. In this respect, Red Blood Cells (RBCs) are emerging as a valid peripheral model for the study of aging-related pathologies. Herein, a small cohort (N = 28) of patients affected by Parkinson’s disease (PD) and age-matched controls were enrolled to detect the content of α-syn (total and oligomeric), Aβ1–42 and tau (total and phosphorylated) in RBCs. Moreover, the presence of α-syn association with tau and Aβ1–42 was explored by co-immunoprecipitation/western blotting in the same cells, and quantitatively confirmed by immunoenzymatic assays. For the first time, PD patients were demonstrated to exhibit α-syn heterocomplexes with Aβ1–42 and tau in peripheral tissues; interestingly, α-syn-Aβ1–42 concentrations were increased in PD subjects with respect to healthy controls (HC), and directly correlated with disease severity and motor deficits. Moreover, total-α-syn levels were decreased in PD subjects and inversely related to their motor deficits. Finally, an increase of oligomeric-α-syn and phosphorylated-tau was observed in RBCs of the enrolled patients. The combination of three parameters (total-α-syn, phosphorylated-tau and α-syn-Aβ1–42 concentrations) provided the best fitting predictive index for discriminating PD patients from controls. Nevertheless further investigations should be required, overall, these data suggest α-syn hetero-aggregates in RBCs as a putative tool for the diagnosis of PD.

4 February 2019 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
ASAngela De Simone
Angela De Simone
VPValeria La Pietra
Valeria La Pietra
NBNibal Betari
Nibal Betari
NPNicola Petragnani
Nicola Petragnani
Mariarosaria ConteMariarosaria Conte
Mariarosaria Conte
AMAndrea Milelli
Andrea Milelli

10 November 2016 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
SDSimona Daniele
Simona Daniele
Simona SestitoSimona Sestito
Simona Sestito
DPDeborah Pietrobono
Deborah Pietrobono
CGChiara Giacomelli
Chiara Giacomelli
GCGrazia Chiellini
Grazia Chiellini
Simona RapposelliSimona Rapposelli
Simona Rapposelli

Verified
Journal Article
Open access
PDF file
CPCarolina Pellegrini
Carolina Pellegrini
SIMONA DANIELESIMONA DANIELE
SIMONA DANIELE
LALuca Antonioli
Luca Antonioli
LBLaura Benvenuti
Laura Benvenuti
VDVanessa D’Antongiovanni
Vanessa D’Antongiovanni
MFMatteo Fornai
Matteo Fornai
Increasing evidence suggests that intestinal dysfunctions may represent early events in Alzheimer’s disease and contribute to brain pathology. This study examined the relationship between onset of cognitive impairment and colonic dysfunctions in a spontaneous AD model before the full development of brain pathology. SAMP8 mice underwent Morris water maze and assessment of faecal output at four, six and eight months of age. In vitro colonic motility was examined. Faecal and colonic Aβ, tau proteins, α-synuclein and IL-1β were assessed by ELISA. Colonic citrate synthase activity was assessed by spectrophotometry. Colonic NLRP3, caspase-1 and ASC expression were evaluated by Western blotting. Colonic eosinophil density and claudin-1 expression were evaluated by immunohistochemistry. The effect of Aβ on NLRP3 signalling and mitochondrial function was tested in cultured cells. Cognitive impairment and decreased faecal output occurred in SAMP8 mice from six months. When compared with SAMR1, SAMP8 animals displayed: (1) impaired in vitro colonic contractions; (2) increased enteric AD-related proteins, IL-1β, active-caspase-1 expression and eosinophil density; and (3) decreased citrate synthase activity and claudin-1 expression. In THP-1 cells, Aβ promoted IL-1β release, which was abrogated upon incubation with caspase-1 inhibitor or in ASC-/- cells. Aβ decreased mitochondrial function in THP-1 cells. In SAMP8, enteric AD-related proteins deposition, inflammation and impaired colonic excitatory neurotransmission, occurring before the full brain pathology development, could contribute to bowel dysmotility and represent prodromal events in AD.

18 April 2017 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
SDSimona Daniele
Simona Daniele
DPDeborah Pietrobono
Deborah Pietrobono
JFJonathan Fusi
Jonathan Fusi
CICaterina Iofrida
Caterina Iofrida
LCLucia Chico
Lucia Chico
Claudia MartiniClaudia Martini
Claudia Martini